ALGS
NASDAQ · Biotechnology
Aligos Therapeutics Inc
$7.32
+0.83 (+12.79%)
Open$6.70
Previous Close$6.49
Day High$7.47
Day Low$6.70
52W High$7.62
52W Low$3.04
Volume—
Avg Volume641.5K
Market Cap45.04M
P/E Ratio57.76
EPS$0.09
SectorBiotechnology
Analyst Ratings
Strong Buy
11 analysts
Price Target
-15.4% upside
Current
$7.32
$7.32
Target
$6.19
$6.19
$4.22
$6.19 avg
$8.57
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 9.95M | 10.09M | 11.15M |
| Net Income | -2,050,765 | -1,613,644 | -1,815,730 |
| Profit Margin | -20.6% | -16.0% | -16.3% |
| EBITDA | -1,999,521 | -2,029,249 | -2,356,621 |
| Free Cash Flow | -1,287,997 | -1,586,727 | -1,930,971 |
| Rev Growth | +6.7% | -9.4% | -9.7% |
| Debt/Equity | 0.15 | 0.13 | 0.14 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $223.43 | +2.01% | 165.4 | 394.89B |
| AMGN | Amgen Inc | $384.32 | +4.49% | 26.8 | 206.95B |
| GILD | Gilead Sciences Inc | $152.50 | +2.10% | 23.3 | 189.20B |
| VRTX | Vertex Pharmaceuticals Inc | $477.92 | +4.17% | 33.7 | 123.82B |
| REGN | Regeneron Pharmaceuticals | $785.51 | +2.46% | 18.4 | 83.03B |
| ALNY | Alnylam Pharmaceuticals Inc | $328.16 | -0.93% | 995.2 | 43.35B |